• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基脲:对其皮肤副作用及其管理的再评价。

Hydroxyurea: a reappraisal of its cutaneous side effects and their management.

机构信息

Department of Dermatology, University of Maryland Medical Center, Baltimore, MD, USA.

Department of Dermatology and Venereology, School of Medicine, Uşak University, Uşak, Turkey.

出版信息

Int J Dermatol. 2021 Jul;60(7):810-817. doi: 10.1111/ijd.15302. Epub 2020 Nov 12.

DOI:10.1111/ijd.15302
PMID:33179784
Abstract

Hydroxyurea (HU) is known to cause a broad spectrum of cutaneous side effects, ranging from relatively benign to severe. Although dermatologists are often consulted for the treatment of these side effects, a comprehensive resource discussing the different types and their management is lacking. In this study, we conducted a literature search in order to critically evaluate the reported types and management of hydroxyurea's cutaneous side effects, as well as review its mechanism of action, dermatologic uses, and common systemic side effects. Relatively common and benign side effects include hyperpigmentation, xerosis, and skin atrophy. While serious cutaneous side effects such as leg ulcers or nonmelanoma skin cancers occur in a substantial proportion of patients, these may resolve with HU discontinuation and proper dermatologic management. Therefore, it is crucial for dermatologists to be aware of these various cutaneous side effects and their management as prompt diagnosis and proper treatment will improve patient outcomes.

摘要

羟脲(HU)已知会引起广泛的皮肤副作用,从相对良性到严重不等。尽管皮肤科医生经常被咨询治疗这些副作用,但缺乏全面的资源来讨论不同类型及其管理。在这项研究中,我们进行了文献检索,以批判性地评估报告的羟脲皮肤副作用的类型和管理,以及审查其作用机制、皮肤科用途和常见的全身副作用。相对常见和良性的副作用包括色素沉着过度、干燥和皮肤萎缩。虽然严重的皮肤副作用,如腿部溃疡或非黑色素瘤皮肤癌,在相当一部分患者中发生,但这些副作用可能会随着 HU 的停用和适当的皮肤科管理而得到解决。因此,皮肤科医生了解这些各种皮肤副作用及其管理至关重要,因为及时诊断和适当的治疗将改善患者的预后。

相似文献

1
Hydroxyurea: a reappraisal of its cutaneous side effects and their management.羟基脲:对其皮肤副作用及其管理的再评价。
Int J Dermatol. 2021 Jul;60(7):810-817. doi: 10.1111/ijd.15302. Epub 2020 Nov 12.
2
[Cutaneous side effects of a long-term treatment by hydroxyurea].[羟基脲长期治疗的皮肤副作用]
Rev Med Brux. 2006 Jan-Feb;27(1):39-41.
3
[Cutaneous side effects of hydroxyurea treatment for polycythemia vera].[羟基脲治疗真性红细胞增多症的皮肤副作用]
Hautarzt. 2009 Oct;60(10):783-7. doi: 10.1007/s00105-009-1844-8.
4
Leg ulcers associated with long-term hydroxyurea therapy.与长期羟基脲治疗相关的腿部溃疡
J Am Acad Dermatol. 1998 Aug;39(2 Pt 2):372-4. doi: 10.1016/s0190-9622(98)70394-9.
5
[Secondary cutaneous effects of hydroxyurea: prospective study of 26 patients from a dermatologic consultation].
Rev Med Interne. 2000 Jan;21(1):30-4. doi: 10.1016/s0248-8663(00)87226-4.
6
Successful treatment of hydroxyurea-associated chronic leg ulcers associated with squamous cell carcinoma.成功治疗与鳞状细胞癌相关的羟基脲所致慢性腿部溃疡。
Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):166-9. doi: 10.1016/j.hemonc.2014.09.008. Epub 2014 Oct 30.
7
Hydroxyurea induced perimalleolar ulcers.羟基脲诱发的内、外踝溃疡。
J Korean Med Sci. 2006 Feb;21(1):177-9. doi: 10.3346/jkms.2006.21.1.177.
8
Leg ulcer in a patient associated with hydroxyurea therapy.一名接受羟基脲治疗的患者出现腿部溃疡。
Int J Dermatol. 2006 Feb;45(2):158-60. doi: 10.1111/j.1365-4632.2004.02450.x.
9
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.羟基脲与一名老年患者同时出现弥漫性纵向黑甲和多发性鳞状细胞癌有关。
Clin Ther. 2008 Jul;30(7):1324-9. doi: 10.1016/s0149-2918(08)80057-4.
10
Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment.长期使用羟基脲治疗导致的手部和足跟部皮肤溃疡。
Eur J Dermatol. 2004 Sep-Oct;14(5):343-6.

引用本文的文献

1
Pathophysiology and Treatment of Psoriasis: From Clinical Practice to Basic Research.银屑病的病理生理学与治疗:从临床实践到基础研究
Pharmaceutics. 2025 Jan 3;17(1):56. doi: 10.3390/pharmaceutics17010056.
2
Hydration of -Hydroxyurea from Ab Initio Molecular Dynamics Simulations.基于从头算分子动力学模拟的α-羟基脲水合作用
Molecules. 2024 May 22;29(11):2435. doi: 10.3390/molecules29112435.
3
Skin Malignancies Due to Anti-Cancer Therapies.抗癌治疗导致的皮肤恶性肿瘤
Cancers (Basel). 2024 May 22;16(11):1960. doi: 10.3390/cancers16111960.
4
Clinical Insights and Dermatological Recommendations for Non-Melanoma Skin Cancers (NMSCs) in Long-Term Hydroxyurea (HU) Therapy.长期羟基脲(HU)治疗非黑色素瘤皮肤癌(NMSC)的临床见解与皮肤科建议
Cureus. 2024 Mar 28;16(3):e57133. doi: 10.7759/cureus.57133. eCollection 2024 Mar.
5
Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?骨髓增殖性肿瘤中的二次癌症发病:是什么、何时、为何?
Int J Mol Sci. 2022 Mar 15;23(6):3177. doi: 10.3390/ijms23063177.
6
Non-melanoma Skin Cancers in Patients on Hydroxyurea for Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Systematic Review.接受羟基脲治疗的费城染色体阴性骨髓增殖性肿瘤患者的非黑色素瘤皮肤癌:一项系统评价
Cureus. 2021 Aug 7;13(8):e16978. doi: 10.7759/cureus.16978. eCollection 2021 Aug.